# Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)

> **NCT01445873** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Sitaxentan sodium

## Key facts

- **NCT ID:** NCT01445873
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-01
- **Primary completion:** 2011-03-28
- **Final completion:** 2011-03-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445873, "Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01445873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*